Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.39 |
| ▸ | MMP13 | P45452 | 1/20 | 0.39 |
| ▸ | FABP4 | P15090 | 2/20 | 0.38 |
| ▸ | FABP3 | P05413 | 1/20 | 0.38 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.36 |
| ▸ | F2 | P00734 | 2/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.35 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.35 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.35 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.35 |
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL5999943 | 0.80 | CA1 (0.58) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL23788 | 0.80 | CA1 (0.58) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL7930818 | 0.80 | CA1 (0.58) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL10846507 | 0.80 | CA1 (0.58) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL28656334 | 0.78 | CA1 (0.56) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL28505545 | 0.78 | CA1 (0.56) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL9711390 | 0.78 | CYP3A4 (0.44) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL9243736 | 0.78 | CA1 (0.56) | CA1CA2MMP1MMP2MMP9 | |
| Water SCHEMBL458685 | 0.78 | CA1 (0.56) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL2549047 | 0.78 | CA1 (0.56) | CA1CA2MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200323986-A1 | HYDROPHOBIC ARENESULFONATE SALTS | THERACAINE LLC | 2020-10-15 | — | — | US | claimed |
| EP-3703686-A1 | HYDROPHOBIC ARENESULFONATE SALTS | Theracaine LLC (US) | 2020-09-09 | — | — | EP | claimed |
| US-20200323986-A1 | HYDROPHOBIC ARENESULFONATE SALTS | THERACAINE LLC | 2020-10-15 | — | — | US | disclosed |
| EP-3703686-A1 | HYDROPHOBIC ARENESULFONATE SALTS | Theracaine LLC (US) | 2020-09-09 | — | — | EP | disclosed |
| EP-2066659-B1 | SUBSTITUTED SULFONAMIDE DERIVATIVES | GRUENENTHAL GMBH (DE) | 2013-08-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200323986-A1 | HYDROPHOBIC ARENESULFONATE SALTS | ARSA, SLC26A3, ABCB11 | CA1 3120/4885CA2 1120/4885MMP1 2814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.